Quantitative analysis of platelet alpha v beta 3 binding to osteopontin using laser tweezers

J Biol Chem. 2003 Dec 19;278(51):51285-90. doi: 10.1074/jbc.M304581200. Epub 2003 Oct 8.

Abstract

To determine whether platelet adhesion to surfaces coated with the matrix protein osteopontin requires an agonist-induced increase in the affinity of the integrin alpha v beta 3 for this ligand, we used laser tweezers to measure the rupture force between single alpha v beta 3 molecules on the platelet surface and osteopontin-coated beads. Virtually all platelets stimulated with 10 microM ADP bound strongly to osteopontin, producing rupture forces as great as 100 piconewtons (pN) with a peak at 45-50 pN. By contrast, 90% of unstimulated, resting non-reactive platelets bound weakly to osteopontin, with rupture forces rarely exceeding 30-35 pN. However, approximately 10% of unstimulated platelets, resting reactive platelets, exhibited rupture force distributions similar to stimulated platelets. Moreover, ADP stimulation resulted in a 12-fold increase in the probability of detecting rupture forces >30 pN compared with resting non-reactive platelets. Pre-incubating stimulated platelets with the inhibitory prostaglandin E1, a cyclic RGD peptide, the monoclonal antibody abciximab, or the alpha v beta 3-specific cyclic peptide XJ735 returned force histograms to those of non-reactive platelets. These experiments demonstrate that ADP stimulation increases the strength of the interaction between platelet alpha v beta 3 and osteopontin. Furthermore, they indicate that platelet adhesion to osteopontin-coated surfaces requires an agonist-induced exposure of alpha v beta 3-binding sites for this ligand.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Abciximab
  • Adenosine Diphosphate / pharmacology
  • Alprostadil / pharmacology
  • Antibodies, Monoclonal / pharmacology
  • Blood Platelets
  • Humans
  • Immunoglobulin Fab Fragments / pharmacology
  • Integrin alphaVbeta3 / metabolism*
  • Lasers*
  • Oligopeptides / pharmacology
  • Osteopontin
  • Platelet Adhesiveness / drug effects
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
  • Protein Binding
  • Sialoglycoproteins / metabolism*

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Integrin alphaVbeta3
  • Oligopeptides
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • SPP1 protein, human
  • Sialoglycoproteins
  • Osteopontin
  • Adenosine Diphosphate
  • arginyl-glycyl-aspartic acid
  • Alprostadil
  • Abciximab